Profile: Medivation, Inc. is a biopharmaceutical company. Our product pipeline consists of small-molecule drugs in clinical development to treat Alzheimer’s disease, Huntington’s disease and hormone-refractory prostate cancer. Our Dimebon™ is an orally-available, small-molecule agent that is being studied in clinical trials for the treatment of Alzheimer’s and Huntington’s disease.